NCT01938352 Evaluation of the Protective Efficacy and Safety of CR8020 in an Influenza Challenge Status COMPLETED Phase PHASE2
NCT01934127 Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age Status COMPLETED Phase PHASE1
NCT01916759 Differences in Response to the Flu Vaccine Among Adults With HIV and Without HIV in Uganda Status COMPLETED Phase NA
NCT01906593 A Post-marketing Safety Study of Beijing Tiantan Biological's Influenza Virus Vaccine in Elderly Status COMPLETED Phase N/A
NCT01893177 Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains (2013-14) Status COMPLETED Phase PHASE3
NCT01891084 The Benefit and Harm of Fever Suppression by Antipyretics in Influenza Status COMPLETED Phase PHASE4
NCT01884519 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine, Fluarix®/Influsplit SSW® (2013/2014 Season), in Adults 18 Years of Age and Older Status COMPLETED Phase PHASE3
NCT01878825 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Trivalent Split Virion Influenza Vaccine Fluviral™ (2013-2014 Season) in Adults Aged 18 Years and Older Status COMPLETED Phase PHASE3
NCT01878812 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine, Fluarix/Influsplit Tetra® (2013/2014 Season), in Adults 18 Years of Age and Older Status COMPLETED Phase PHASE3
NCT01867021 Immunogenicity, Safety and Tolerability of a Trivalent Subunit Inactivated Vaccine in Healthy Subjects 50 Years and Above Status COMPLETED Phase PHASE4
NCT01859143 Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults Status COMPLETED Phase PHASE4
NCT01857206 Safety of Two Trivalent Influenza Vaccines Evaluated in Children and Adolescents 4 to 17 Years of Age Status COMPLETED Phase PHASE3
NCT01854632 Clinical Efficacy of Trivalent Live-Attenuated Influenza Vaccine (LAIV) Among Children in Senegal Status COMPLETED Phase PHASE3
NCT01850446 Comparative Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza Status COMPLETED Phase PHASE4
NCT01839760 Evaluation of Viral Shedding Patterns and Clinical Outcomes of Influenza Patients Status COMPLETED Phase N/A